Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results

Journal of Infectious Diseases

Volumn 201, Issue 1, 2010, Pages 20-31

  Babu, Subash ^a,c,e   Bhat, Sajid Q ^a   Pavan Kumar, N ^a   Kumaraswami, V ^a,b   Nutman, Thomas B ^d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e NIH ICER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 17; INTERLEUKIN 23;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH17 CELL; TUBERCULIN TEST;

ADOLESCENT; ADULT; ANTIGENS, CD; CASE-CONTROL STUDIES; CELLS, CULTURED; DOWN-REGULATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TUBERCULIN TEST; YOUNG ADULT;

EID: 71949122836     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/648735     Document Type: Article

References (50)

1. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974; 99:131-138
2. Lillebaek T, Dirksen A, Baess I, et al. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J Infect Dis 2002; 185:401-404
3. Wayne LG, Sohaskey CD. Nonreplicating persistence of Mycobacterium tuberculosis. Annu Rev Microbiol 2001; 55:139-163
4. Edwards PQ, Edwads LB. Story of the tuberculin test from an epidemiologic viewpoint. Am Rev Respir Dis 1960; 81:1-47.
5. Vinton P, Mihrshahi S, Johnson P, et al. Comparison of QuantiFERONTB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection. Infect Control Hosp Epidemiol 2009; 30:215-221
6. Radhakrishna S, Frieden TR, Subramani R. Association of initial tuberculin sensitivity, age and sex with the incidence of tuberculosis in south India: a 15-year follow-up. Int J Tuberc Lung Dis 2003; 7:1083-1091
7. Lin MY, Ottenhoff TH. Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection. Biol Chem 2008; 389:497-511.
8. 8. Locht C, Rouanet C, Hougardy JM, Mascart F. How a different look at latency can help to develop novel diagnostics and vaccines against tuberculosis. Expert Opin Biol Ther 2007; 7:1665-1677 (Pubitemid 350157493)
9. Kaufmann SH. How can immunology contribute to the control of tuberculosis? Nat Rev Immunol 2001; 1:20-30.
10. Khader SA, Cooper AM. IL-23 and IL-17 in tuberculosis. Cytokine 2008; 41:79-83.
11. North RJ, Jung YJ. Immunity to tuberculosis. Annu Rev Immunol 2004; 22:599-623.
12. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005; 23:515-548
13. Li MO, Flavell RA. Contextual regulation of inflammation: a duet by transforming growth factor-β and interleukin-10. Immunity 2008; 28: 468-476
14. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22:531-562
15. 15. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-1061 (Pubitemid 36222930)
16. + T helper cells. Cell 2006; 126:1121-1133
17. Jurado JO, Alvarez IB, Pasquinelli V, et al. Programmed death (PD)1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol 2008; 181:116-125
18. 18. Kirman J, McCoy K, Hook S, et al. CTLA-4 blockade enhances the immune response induced by mycobacterial infection but does not lead to increased protection. Infect Immun 1999; 67:3786-3792 (Pubitemid 29356993)
19. + Treg cells inhibit human memory γδ T cells to produce IFN-γ in response to M. tuberculosis antigen ESAT-6. Blood 2008; 111:5629-5636
20. 20. Roberts T, Beyers N, Aguirre A, Walzl G. Immunosuppression during active tuberculosis is characterized by decreased interferon-γ production and CD25 expression with elevated forkhead box P3, transforming growth factor-β, and interleukin-4 mRNA levels. J Infect Dis 2007; 195:870-878 (Pubitemid 46363933)
21. 21. Scott-Browne JP, Shafiani S, Tucker-Heard G, et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med 2007; 204:2159-2169 (Pubitemid 47360876)
22. Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol 2002; 2:933-944
23. 23. Fontenot JD, Rudensky AY. Molecular aspects of regulatory T cell development. Semin Immunol 2004; 16:73-80. (Pubitemid 38234758)
24. McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road. Immunity 2008; 28:445-453
25. Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 2008; 8: 247-258
26. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25:821-852
27. Flynn JL. Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect 2006; 8:1179-1188
28. Holland SM. Interferon γ, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity. Immunol Res 2007; 38:342-346
29. 29. Jacobs M, Samarina A, Grivennikov S, et al. Reactivation of tuberculosis by tumor necrosis factor neutralization. Eur Cytokine Netw 2007; 18:5-13. (Pubitemid 46848053)
30. 30. Liebeschuetz S, Bamber S, Ewer K, et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004; 364:2196-2203 (Pubitemid 40018449)
31. + T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 2008; 180:1962-1970.
32. 32. Weir RE, Gorak-Stolinska P, Floyd S, et al. Persistence of the immune response induced by BCG vaccination. BMC Infect Dis 2008; 8:9. (Pubitemid 351359616)
33. Kahnert A, Seiler P, Stein M, et al. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. Eur J Immunol 2006; 36:631-647
34. H17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nat Immunol 2008; 9:641-649
35. - T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007; 8: 369-377
36. 36. Khader SA, Pearl JE, Sakamoto K, et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFNy responses if IL-12p70 is available. J Immunol 2005; 175:788-795 (Pubitemid 41094960)
37. Umemura M, Yahagi A, Hamada S, et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guérin infection. J Immunol 2007; 178:3786-3796
38. Wozniak TM, Ryan AA, Triccas JA, Britton WJ. Plasmid interleukin23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. Infect Immun 2006; 74:557-565
39. 39. Dheda K, Chang JS, Lala S, et al. Gene expression of IL17 and IL23 in the lungs of patients with active tuberculosis. Thorax 2008; 63:566-568 (Pubitemid 351831173)
40. Pasquinelli V, Townsend JC, Jurado JO, et al. IFN-γ production during active tuberculosis is regulated by mechanisms that involve IL-17, SLAM, and CREB. J Infect Dis 2009; 199:661-665
41. Peng MY, Wang ZH, Yao CY, et al. Interleukin 17-producing γδ T cells increased in patients with active pulmonary tuberculosis. Cell Mol Immunol 2008; 5:203-208
42. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008; 8:523-532
43. H17 and regulatory T cells. Nature 2006; 441:235-238
44. H17 cell differentiation by antagonizing RORγt function. Nature 2008; 453:236-240
45. H17 cells. Nature 2007; 448:484-487
46. H17 lineage. Nature 2006; 441: 231-234
47. H17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317:256-260
48. H17 cells. Nature 2008; 454: 350-352
49. Cheng X, Yu X, Ding YJ, et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008; 127:89-97.
50. Nistala K, Moncrieffe H, Newton KR, et al. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum 2008; 58:875-887